Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01112995 · ClinicalTrials.gov registry record · Phase 2
A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT01112995 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 49 participants.
The verdict
NCT01112995, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the feasibility, safety and efficacy of oral probiotic, Lactobacillus rhamnosus versus oral placebo for reducing colonization by MRSA.
Interventions
- DIETARY_SUPPLEMENT Lactobacillus rhamnosus
- DIETARY_SUPPLEMENT Sugar pill (placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01112995
The ClinicalTrials.gov registry entry for NCT01112995 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lactobacillus rhamnosus is the first listed.
NCT01112995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01112995 about?
NCT01112995 is a clinical study titled "A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)". The purpose of this study is to investigate the feasibility, safety and efficacy of oral probiotic, Lactobacillus rhamnosus versus oral placebo for reducing colonization by MRSA.
What is the current status of trial NCT01112995?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2010-01. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01112995?
The interventions under investigation include: Lactobacillus rhamnosus (DIETARY_SUPPLEMENT), Sugar pill (placebo) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01112995?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.